Hypoxic preconditioning protects against ischemic brain injury

SummaryAnimals exposed to brief periods of moderate hypoxia (8% to 10% oxygen for 3 hours) are protected against cerebral and cardiac ischemia between 1 and 2 days later. This hypoxia preconditioning requires new RNA and protein synthesis. The mechanism of this hypoxia-induced tolerance correlates with the induction of the hypoxia-inducible factor (HIF), a transcription factor heterodimeric complex composed of inducible HIF-1α and constitutive HIF-1β proteins that bind to the hypoxia response elements in a number of HIF target genes. Our recent studies show that HIF-1α correlates with hypoxia induced tolerance in neonatal rat brain. HIF target genes, also induced following hypoxia-induced tolerance, include vascular endothelial growth factor, erythropoietin, glucose transporters, glycolytic enzymes, and many other genes. Some or all of these genes may contribute to hypoxia-induced protection against ischemia. HIF induction of the glycolytic enzymes accounts in part for the Pasteur effect in brain and other tissues. Hypoxia-induced tolerance is not likely to be equivalent to treatment with a single HIF target gene protein since other transcription factors including Egr-1 (NGFI-A) have been implicated in hypoxia regulation of gene expression. Understanding the mechanisms and genes involved in hypoxic tolerance may provide new therapeutic targets to treat ischemic injury and enhance recovery.

[1]  N. Maulik,et al.  Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF kappa B-dependent mechanism in a rat model of chronic myocardial infarction. , 2001, Journal of molecular and cellular cardiology.

[2]  P. Ratcliffe,et al.  New insights into an enigmatic tumour suppressor , 2003, Nature Cell Biology.

[3]  P Ghezzi,et al.  Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[5]  D. Klimanis,et al.  TNF-α–Induced Tolerance to Ischemic Injury Involves Differential Control of NF-κB Transactivation: The Role of NF-κB Association with p300 Adaptor , 2002 .

[6]  M. Bernaudin,et al.  Brain Genomic Response following Hypoxia and Re-oxygenation in the Neonatal Rat , 2002, The Journal of Biological Chemistry.

[7]  Pietro Ghezzi,et al.  Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Ratcliffe,et al.  Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.

[9]  K. N. Dudkin,et al.  The Adaptive Effects of Hypoxic Preconditioning of Brain Neurons , 2004, Neuroscience and Behavioral Physiology.

[10]  K. S. Lee,et al.  Ischemic tolerance in the rat neocortex following hypothermic preconditioning. , 2000, Journal of neurosurgery.

[11]  E. Kaptanoğlu,et al.  Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain , 2002, Child's Nervous System.

[12]  J. Engelhardt,et al.  Tyrosine Phosphorylation of IκBα Activates NFκB through a Redox-regulated and c-Src-dependent Mechanism Following Hypoxia/Reoxygenation* , 2003, The Journal of Biological Chemistry.

[13]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[14]  J. Caro,et al.  Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element , 2000, Molecular and Cellular Biochemistry.

[15]  G. Lu,et al.  Changes of Adenosine and Its A1 Receptor in Hypoxic Preconditioning , 1999, Neurosignals.

[16]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .

[17]  L. Neckers,et al.  Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. , 2003, The Biochemical journal.

[18]  G. Semenza,et al.  Induction of hypoxia‐inducible factor‐1 (HIF‐1) and its target genes following focal ischaemia in rat brain , 1999, The European journal of neuroscience.

[19]  T. Kirino Ischemic Tolerance , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Huang,et al.  Hypoxia-inducible Factor and Its Biomedical Relevance* , 2003, Journal of Biological Chemistry.

[22]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[23]  P. Carmeliet,et al.  Hypoxia-inducible Factor-2α (HIF-2α) Is Involved in the Apoptotic Response to Hypoglycemia but Not to Hypoxia* , 2001, The Journal of Biological Chemistry.

[24]  G. Semenza,et al.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.

[25]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[26]  D. Gozal,et al.  Excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lactate transport inhibition in rat hippocampal slices , 2001, Neuroscience Letters.

[27]  P. Ratcliffe,et al.  Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. , 1998, The Journal of experimental biology.

[28]  S. Brooke,et al.  Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events , 2001, Brain Research.

[29]  Ç. Ulukuş,et al.  Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2003, Neonatology.

[30]  Nigel Mackman,et al.  Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.

[31]  R. Keep,et al.  The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? , 2002, Journal of neurochemistry.

[32]  L. Neckers,et al.  Microtubule Disruption Utilizes an NFκB-dependent Pathway to Stabilize HIF-1α Protein* , 2003, The Journal of Biological Chemistry.

[33]  Masafumi Tagaya,et al.  ‘Ischemic tolerance’ phenomenon detected in various brain regions , 1991, Brain Research.

[34]  M. O'Neill,et al.  NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. , 1999, European journal of pharmacology.

[35]  A. Bauer,et al.  Regulation of tyrosine hydroxylase promoter activity by the von Hippel–Lindau tumor suppressor protein and hypoxia‐inducible transcription factors , 2003, Journal of neurochemistry.

[36]  Andrew L. Kung,et al.  Suppression of tumor growth through disruption of hypoxia-inducible transcription , 2000, Nature Medicine.

[37]  J. Elkins,et al.  Structure of Factor-inhibiting Hypoxia-inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1α* , 2003, The Journal of Biological Chemistry.

[38]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[39]  S. Bhattacharya,et al.  An essential role for p300/CBP in the cellular response to hypoxia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Shirato,et al.  Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. , 2001, Biochemical and biophysical research communications.

[41]  S. Antonarakis,et al.  Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Sharp,et al.  Multiple Molecular Penumbras after Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  D. Klimanis,et al.  Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma , 2001, Brain Research.

[44]  G. Lu,et al.  Downregulation of nitric oxide in the brain of mice during their hypoxic preconditioning. , 2001, Journal of applied physiology.

[45]  P. Ratcliffe,et al.  Oxygen sensors and angiogenesis. , 2002, Seminars in cell & developmental biology.

[46]  S. Kourembanas,et al.  Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. , 1995, Circulation research.

[47]  T Kobayashi,et al.  Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. , 2001, Genes & development.

[48]  P. Carmeliet,et al.  Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .

[49]  D. Ferriero,et al.  Hypoxia-Ischemia, but Not Hypoxia Alone, Induces the Expression of Heme Oxygenase-1 (HSP32) in Newborn Rat Brain , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  E. Mackenzie,et al.  A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  B. Zbar,et al.  Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. , 1999, The Journal of clinical investigation.

[52]  R. Mentzer,et al.  Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. , 1993, Cardiovascular research.

[53]  P. Ratcliffe,et al.  Hypoxia response elements. , 1997, Oncology research.

[54]  S. Nelson,et al.  Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats , 1999, Brain Research.

[55]  A. Buchan,et al.  Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia , 1999, Neurology.

[56]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[57]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[58]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[59]  F. Sharp,et al.  Blood Genomic Expression Profile for Neuronal Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  A. Koong,et al.  Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.

[61]  E. Morishita,et al.  In vivo evidence that erythropoietin protects neurons from ischemic damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. L. Fink,et al.  An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid , 2000, Brain Research.

[63]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[64]  G. Semenza,et al.  Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin , 1999, The Journal of Neuroscience.

[65]  A. Rizzino,et al.  Stimulation of the murine type II transforming growth factor‐β receptor promoter by the transcription factor Egr‐1 , 2002, Molecular reproduction and development.

[66]  F. Squadrito,et al.  Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. , 2002, European journal of pharmacology.

[67]  U. Dirnagl,et al.  Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons , 1998, Neuroscience Letters.

[68]  T. Collins,et al.  Extinguishing Egr‐1‐dependent inflammatory and thrombotic cascades following lung transplantation , 2001 .

[69]  G. Semenza,et al.  Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[70]  M. Ivan,et al.  The von Hippel-Lindau tumor suppressor protein. , 2001, Current opinion in genetics & development.

[71]  T. Purshottam,et al.  Hypoxia tolerance in rats in relation to tissue glycogen levels. , 1978, Aviation Space and Environmental Medicine.

[72]  P. Ratcliffe,et al.  The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma , 2001, Oncogene.

[73]  A. Shah,et al.  Nitric Oxide Mediates Cerebral Ischemic Tolerance in a Neonatal Rat Model of Hypoxic Preconditioning , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[74]  M. Ivan,et al.  Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.

[75]  W. Kaelin,et al.  The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. , 1998, Genes & development.

[76]  G. Semenza,et al.  Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[77]  啓明 佐々木 Hypoxia/reoxygenation promotes myocardial angiogenesis via an NFκB-dependent mechanism in a rat model of chronic myocardial infarction , 2003 .

[78]  R. Mallet,et al.  Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusions in dog heart. , 1993, Cardiovascular research.

[79]  M. Lazdunski,et al.  Activation of the Nuclear Factor-κB Is a Key Event in Brain Tolerance , 2001, The Journal of Neuroscience.

[80]  P. Stanton,et al.  Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor , 1996, Brain Research.

[81]  Christopher J Schofield,et al.  Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.

[82]  貞本 泰孝 Erythropoietin Prevents Place Navigation Disability and Cortical Infarction in Rats with Permanent Occlusion of the Middle Cerebral Artery , 2000 .

[83]  M. Krug,et al.  The importance of free hydroxyl radicals to hypoxia preconditioning , 2000, Brain Research.

[84]  K. Jungermann,et al.  Cross-talk between the signals hypoxia and glucose at the glucose response element of the L-type pyruvate kinase gene. , 2001, Endocrinology.

[85]  G. Zhao,et al.  Tissue plasminogen activator protects hippocampal neurons from oxygen‐glucose deprivation injury , 2001, Journal of neuroscience research.

[86]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[87]  Christopher J. Schofield,et al.  Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL , 2002, Nature.

[88]  K. Jungermann,et al.  Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. , 2003, Blood.

[89]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[90]  F. Sharp Stress genes protect brain , 1998, Annals of neurology.

[91]  R. Currie,et al.  Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27 , 2000, Brain Research.

[92]  A. Shah,et al.  Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat , 1994, Neuroscience Letters.

[93]  Ding-I Yang,et al.  iNOS expression inhibits hypoxia-inducible factor-1 activity. , 2000, Biochemical and biophysical research communications.

[94]  P. Ratcliffe,et al.  Regulation of HIF by the von Hippel‐Lindau Tumour Suppressor: Implications for Cellular Oxygen Sensing , 2001, IUBMB life.

[95]  F. Sharp,et al.  The stress gene response in brain. , 1996, Cerebrovascular and brain metabolism reviews.

[96]  F. Samson,et al.  Effects of hypoxia preconditioning on expression of metallothionein-1,2 and heme oxygenase-1 before and after kainic acid-induced seizures. , 2000, Cellular and molecular biology.

[97]  U. Dirnagl,et al.  Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism? , 2002, Neuroreport.

[98]  R. Simon,et al.  Ischemic tolerance in the brain , 1997, Neurology.

[99]  H. Nakase,et al.  Increased Hypoxic Tolerance by Chemical Inhibition of Oxidative Phosphorylation: “Chemical Preconditioning” , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  L. Neckers,et al.  Stabilization of wild-type p53 by hypoxia-inducible factor 1α , 1998, Nature.

[101]  Jan Neckář,et al.  Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive , 2001, Basic Research in Cardiology.

[102]  R. Sapolsky,et al.  Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Brandon A. Miller,et al.  Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion , 2001, Neuroreport.

[104]  G. Semenza,et al.  Role of hypoxia‐inducible factor‐1 in hypoxia‐induced ischemic tolerance in neonatal rat brain , 2000, Annals of neurology.

[105]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[106]  R. Currie,et al.  Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. , 1998, Stroke.

[107]  S. Tsirka Tissue plasminogen activator as a modulator of neuronal survival and function. , 2001, Biochemical Society transactions.

[108]  H. Zhu,et al.  Signal transduction. How do cells sense oxygen? , 2001, Science.

[109]  A. Cerami,et al.  Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[110]  T. Sick,et al.  Anoxic preconditioning in hippocampal slices: role of adenosine , 1996, Neuroscience.

[111]  B. Aronow,et al.  Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia , 2002, The European journal of neuroscience.

[112]  F R Sharp,et al.  Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: Blood genomic fingerprints of disease , 2001, Annals of neurology.

[113]  W. Makałowski,et al.  Hypoxia induces mitochondrial DNA damage and stimulates expression of a DNA repair enzyme, the Escherichia coli MutY DNA glycosylase homolog (MYH), in vivo, in the rat brain , 2002, Journal of neurochemistry.

[114]  M. Bernaudin,et al.  Hypoxia-inducible factor in brain. , 2001, Advances in experimental medicine and biology.

[115]  E. Jacobsohn,et al.  Ischaemic preconditioning: mechanisms and potential clinical applications , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[116]  K. Jungermann,et al.  Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements. , 2002, Biochemical pharmacology.

[117]  Eamonn R. Maher,et al.  Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.

[118]  R. Vannucci,et al.  Hypoxic Preconditioning Increases Brain Glycogen and Delays Energy Depletion from Hypoxia-Ischemia in the Immature Rat , 2003, Developmental Neuroscience.

[119]  U. Dirnagl,et al.  Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in Vitro , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[120]  M. Buemi,et al.  Erythropoietin and the brain: from neurodevelopment to neuroprotection. , 2002, Clinical science.

[121]  U. Dirnagl,et al.  Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model , 2002, The Journal of Neuroscience.

[122]  P. Ratcliffe,et al.  Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor* , 2001, The Journal of Biological Chemistry.

[123]  J. Hallenbeck,et al.  Cell Permeable Exogenous Ceramide Reduces Infarct Size in Spontaneously Hypertensive Rats Supporting In Vitro Studies That Have Implicated Ceramide in Induction of Tolerance to Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[124]  D. Livingston,et al.  Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Chemical preconditioning: A cytoprotective strategy , 1997 .

[126]  M. Bennett,et al.  Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[127]  E. Englander,et al.  Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells. , 2000, Nucleic acids research.

[128]  ChengXiang Zhai,et al.  Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Kentaro Takahashi,et al.  Von Hippel-Lindau Disease , 2024 .

[130]  Weining Lu,et al.  Cloning and functional analysis of the mouse 5-lipoxygenase promoter. , 2002, American journal of respiratory cell and molecular biology.

[131]  R. Mallet,et al.  Hypoxic preconditioning of ischaemic canine myocardium. , 1992, Cardiovascular research.

[132]  Liliana Attisano,et al.  Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.

[133]  J. Bryan,et al.  Ischemic Preconditioning in the Hippocampus of a Knockout Mouse Lacking SUR1-Based KATP Channels , 2003, Stroke.

[134]  T. Toyoda,et al.  Hypothermia‐Induced Ischemic Tolerance , 1999, Annals of the New York Academy of Sciences.

[135]  E. Mackenzie,et al.  Normobaric Hypoxia Induces Tolerance to Focal Permanent Cerebral Ischemia in Association with an Increased Expression of Hypoxia-Inducible Factor-1 and its Target Genes, Erythropoietin and VEGF, in the Adult Mouse Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[136]  Mircea Ivan,et al.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[137]  M. Halterman,et al.  Hypoxia-Inducible Factor-1α Mediates Hypoxia-Induced Delayed Neuronal Death That Involves p53 , 1999, The Journal of Neuroscience.

[138]  K. Shimoji,et al.  A forebrain ischemic preconditioning model established in C57Black/Crj6 mice , 2001, Journal of Neuroscience Methods.

[139]  H. Bunn,et al.  How Do Cells Sense Oxygen? , 2001, Science.

[140]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.

[141]  K. Reymann,et al.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[142]  T. Fojo,et al.  p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription* , 1998, The Journal of Biological Chemistry.

[143]  J. Gidday,et al.  Mouse models of retinal ischemic tolerance. , 2002, Investigative ophthalmology & visual science.

[144]  M. Venkatachalam,et al.  Gene promoter of apoptosis inhibitory protein IAP2: identification of enhancer elements and activation by severe hypoxia. , 2002, The Biochemical journal.

[145]  T. Kawamoto,et al.  Identification of Functional Hypoxia Response Elements in the Promoter Region of the DEC1 and DEC2 Genes* , 2002, The Journal of Biological Chemistry.

[146]  M. Braddock,et al.  Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[147]  R. Vannucci,et al.  Hypoxic Preconditioning and Hypoxic‐Ischemic Brain Damage in the Immature Rat: Pathologic and Metabolic Correlates , 1998, Journal of neurochemistry.

[148]  D. Epner,et al.  Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. , 2002, Biochimica et biophysica acta.

[149]  M. Bernaudin,et al.  Glial expression of heat shock proteins (HSPs) and oxygen-regulated proteins (ORPs). , 2001, Progress in brain research.

[150]  S. Nelson,et al.  A global hypoxia preconditioning model: neuroprotection against seizure-induced specific gravity changes (edema) and brain damage in rats. , 1999, Brain research. Brain research protocols.

[151]  Y. Yuan,et al.  Gene regulation during hypoxia in excitable oxygen-sensing cells: depolarization-transcription coupling. , 2000, Advances in experimental medicine and biology.

[152]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[153]  R. Simon,et al.  Stress Proteins and Tolerance to Focal Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[154]  L. Bianchi,et al.  HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. , 1999, Nucleic acids research.

[155]  G. Yancopoulos,et al.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. , 2002, The Journal of clinical investigation.

[156]  M. Marber,et al.  Hypoxic preconditioning of ischaemic myocardium. , 1992, Cardiovascular research.

[157]  R. Auer,et al.  Hypoxia, hyperoxia, ischemia, and brain necrosis , 2000, Neurology.

[158]  F. Tomasello,et al.  Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. , 2000, European journal of pharmacology.

[159]  A. Lochner,et al.  Preconditioning with hypoxia versus global ischemia in the isolated rat heart: effect on function and metabolism. , 1994, Cardioscience.

[160]  G. Semenza,et al.  Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.

[161]  D. Katayose,et al.  Acute ischaemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. , 1994, Cardiovascular research.

[162]  G. Greeley,et al.  Rat MYH, a glycosylase for repair of oxidatively damaged DNA, has brain‐specific isoforms that localize to neuronal mitochondria , 2002, Journal of neurochemistry.

[163]  N. Jones,et al.  Hypoxic Preconditioning Induces Changes in HIF-1 Target Genes in Neonatal Rat Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[164]  G. Semenza Angiogenesis in ischemic and neoplastic disorders. , 2003, Annual review of medicine.

[165]  R. Simon Hypoxia versus ischemia , 1999, Neurology.

[166]  G. Greeley,et al.  Hypoxia‐induced mitochondrial and nuclear DNA damage in the rat brain , 1999, Journal of neuroscience research.

[167]  Mao-tsun Lin,et al.  Chronic Hypoxia Preconditioning Increases Survival In Rats Suffering From Heatstroke , 2002, Clinical and experimental pharmacology & physiology.

[168]  J. LaManna,et al.  Activation of Hypoxia-Inducible Factor-1 in the Rat Cerebral Cortex after Transient Global Ischemia: Potential Role of Insulin-Like Growth Factor-1 , 2002, The Journal of Neuroscience.

[169]  J. Dichgans,et al.  Neuroprotection by Hypoxic Preconditioning Requires Sequential Activation of Vascular Endothelial Growth Factor Receptor and Akt , 2002, The Journal of Neuroscience.

[170]  D M Stern,et al.  A pathway leading to hypoxia-induced vascular fibrin deposition. , 2000, Seminars in thrombosis and hemostasis.

[171]  G. Grasso,et al.  Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. , 2001, Journal of neurosurgical sciences.

[172]  P. Lewczuk,et al.  Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.

[173]  F. Sharp,et al.  Cloning of rat grp75, an hsp70‐family member, and its expression in normal and ischemic brain , 1995, Journal of neuroscience research.

[174]  Z. Kleinrok,et al.  The role of opioid receptors in hypoxic preconditioning against seizures in brain , 2000, Pharmacology Biochemistry and Behavior.

[175]  G. Semenza Oxygen-regulated transcription factors and their role in pulmonary disease , 2000, Respiratory research.